Bad blood: secrets and lies in a Silicon Valley startup
In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors s...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
New York
Alfred A. Knopf
2019
|
| Ausgabe: | First edition |
| Schriftenreihe: | A Borzoi book
|
| Schlagworte: | |
| Zusammenfassung: | In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When John Carreyrou, working at The Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. The biggest corporate fraud since Enron is a cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley |
| Beschreibung: | x, 339 Seiten 25 cm |
| ISBN: | 9781524731656 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV045091432 | ||
| 003 | DE-604 | ||
| 005 | 20190311 | ||
| 007 | t | ||
| 008 | 180718s2019 b||| 00||| eng d | ||
| 020 | |a 9781524731656 |c (hardback) |9 978-1-5247-3165-6 | ||
| 035 | |a (OCoLC)1035523266 | ||
| 035 | |a (DE-599)BVBBV045091432 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-473 |a DE-188 | ||
| 082 | 0 | |a 338.7681761 |2 23 | |
| 084 | |a QP 230 |0 (DE-625)141847: |2 rvk | ||
| 100 | 1 | |a Carreyrou, John |e Verfasser |0 (DE-588)1164175270 |4 aut | |
| 245 | 1 | 0 | |a Bad blood |b secrets and lies in a Silicon Valley startup |c John Carreyrou |
| 250 | |a First edition | ||
| 264 | 1 | |a New York |b Alfred A. Knopf |c 2019 | |
| 300 | |a x, 339 Seiten |c 25 cm | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a A Borzoi book | |
| 505 | 8 | |a A purposeful life -- The gluebot -- Apple envy -- Goodbye East Paly -- The childhood neighbor -- Sunny -- Dr. J -- The miniLab -- The wellness play -- "Who is LTC Shoemaker?" -- Lighting a Fuisz -- Ian Gibbons -- Chiat\Day -- Going live -- Unicorn -- The grandson -- Fame -- The Hippocratic Oath -- The tip -- The ambush -- Trade secrets -- La mattanza -- Damage control -- The empress has no clothes -- Epilogue | |
| 520 | 3 | |a In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When John Carreyrou, working at The Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. The biggest corporate fraud since Enron is a cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley | |
| 600 | 3 | 4 | |a Holmes, Elizabeth Anne |z 1984- |
| 610 | 2 | 4 | |a Theranos (Firm) |x History |
| 610 | 2 | 7 | |a Theranos Inc. |0 (DE-588)1162212322 |2 gnd |9 rswk-swf |
| 610 | 2 | 7 | |a Europäische Kommission |b Startup Project |0 (DE-588)1086334183 |2 gnd |9 rswk-swf |
| 648 | 7 | |a Geschichte |2 gnd |9 rswk-swf | |
| 650 | 4 | |a Hematologic equipment industry |z United States | |
| 650 | 4 | |a New business enterprises / Corrupt practices / United States / Case studies |x Corrupt practices |z United States |x Case studies | |
| 650 | 4 | |a Securities fraud |z United States |x Case studies | |
| 650 | 4 | |a Fraud |z United States | |
| 650 | 0 | 7 | |a Betrug |0 (DE-588)4006249-1 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Theranos Inc. |0 (DE-588)1162212322 |D b |
| 689 | 0 | 1 | |a Europäische Kommission |b Startup Project |0 (DE-588)1086334183 |D b |
| 689 | 0 | 2 | |a Betrug |0 (DE-588)4006249-1 |D s |
| 689 | 0 | |8 1\p |5 DE-604 | |
| 689 | 1 | 0 | |a Theranos Inc. |0 (DE-588)1162212322 |D b |
| 689 | 1 | 1 | |a Geschichte |A z |
| 689 | 1 | |8 2\p |5 DE-604 | |
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |z 978-1-5247-3165-6 |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-030482199 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
Datensatz im Suchindex
| _version_ | 1804178715569029120 |
|---|---|
| any_adam_object | |
| author | Carreyrou, John |
| author_GND | (DE-588)1164175270 |
| author_facet | Carreyrou, John |
| author_role | aut |
| author_sort | Carreyrou, John |
| author_variant | j c jc |
| building | Verbundindex |
| bvnumber | BV045091432 |
| classification_rvk | QP 230 |
| contents | A purposeful life -- The gluebot -- Apple envy -- Goodbye East Paly -- The childhood neighbor -- Sunny -- Dr. J -- The miniLab -- The wellness play -- "Who is LTC Shoemaker?" -- Lighting a Fuisz -- Ian Gibbons -- Chiat\Day -- Going live -- Unicorn -- The grandson -- Fame -- The Hippocratic Oath -- The tip -- The ambush -- Trade secrets -- La mattanza -- Damage control -- The empress has no clothes -- Epilogue |
| ctrlnum | (OCoLC)1035523266 (DE-599)BVBBV045091432 |
| dewey-full | 338.7681761 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 338 - Production |
| dewey-raw | 338.7681761 |
| dewey-search | 338.7681761 |
| dewey-sort | 3338.7681761 |
| dewey-tens | 330 - Economics |
| discipline | Wirtschaftswissenschaften |
| edition | First edition |
| era | Geschichte gnd |
| era_facet | Geschichte |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03688nam a2200565 c 4500</leader><controlfield tag="001">BV045091432</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20190311 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">180718s2019 b||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781524731656</subfield><subfield code="c">(hardback)</subfield><subfield code="9">978-1-5247-3165-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1035523266</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV045091432</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-473</subfield><subfield code="a">DE-188</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">338.7681761</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QP 230</subfield><subfield code="0">(DE-625)141847:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Carreyrou, John</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1164175270</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Bad blood</subfield><subfield code="b">secrets and lies in a Silicon Valley startup</subfield><subfield code="c">John Carreyrou</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">First edition</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York</subfield><subfield code="b">Alfred A. Knopf</subfield><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">x, 339 Seiten</subfield><subfield code="c">25 cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">A Borzoi book</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">A purposeful life -- The gluebot -- Apple envy -- Goodbye East Paly -- The childhood neighbor -- Sunny -- Dr. J -- The miniLab -- The wellness play -- "Who is LTC Shoemaker?" -- Lighting a Fuisz -- Ian Gibbons -- Chiat\Day -- Going live -- Unicorn -- The grandson -- Fame -- The Hippocratic Oath -- The tip -- The ambush -- Trade secrets -- La mattanza -- Damage control -- The empress has no clothes -- Epilogue</subfield></datafield><datafield tag="520" ind1="3" ind2=" "><subfield code="a">In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When John Carreyrou, working at The Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. The biggest corporate fraud since Enron is a cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley</subfield></datafield><datafield tag="600" ind1="3" ind2="4"><subfield code="a">Holmes, Elizabeth Anne</subfield><subfield code="z">1984-</subfield></datafield><datafield tag="610" ind1="2" ind2="4"><subfield code="a">Theranos (Firm)</subfield><subfield code="x">History</subfield></datafield><datafield tag="610" ind1="2" ind2="7"><subfield code="a">Theranos Inc.</subfield><subfield code="0">(DE-588)1162212322</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="610" ind1="2" ind2="7"><subfield code="a">Europäische Kommission</subfield><subfield code="b">Startup Project</subfield><subfield code="0">(DE-588)1086334183</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="648" ind1=" " ind2="7"><subfield code="a">Geschichte</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hematologic equipment industry</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">New business enterprises / Corrupt practices / United States / Case studies</subfield><subfield code="x">Corrupt practices</subfield><subfield code="z">United States</subfield><subfield code="x">Case studies</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Securities fraud</subfield><subfield code="z">United States</subfield><subfield code="x">Case studies</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Fraud</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Betrug</subfield><subfield code="0">(DE-588)4006249-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Theranos Inc.</subfield><subfield code="0">(DE-588)1162212322</subfield><subfield code="D">b</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Europäische Kommission</subfield><subfield code="b">Startup Project</subfield><subfield code="0">(DE-588)1086334183</subfield><subfield code="D">b</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Betrug</subfield><subfield code="0">(DE-588)4006249-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Theranos Inc.</subfield><subfield code="0">(DE-588)1162212322</subfield><subfield code="D">b</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Geschichte</subfield><subfield code="A">z</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield><subfield code="z">978-1-5247-3165-6</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-030482199</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield></record></collection> |
| id | DE-604.BV045091432 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:08:22Z |
| institution | BVB |
| isbn | 9781524731656 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-030482199 |
| oclc_num | 1035523266 |
| open_access_boolean | |
| owner | DE-473 DE-BY-UBG DE-188 |
| owner_facet | DE-473 DE-BY-UBG DE-188 |
| physical | x, 339 Seiten 25 cm |
| publishDate | 2019 |
| publishDateSearch | 2019 |
| publishDateSort | 2019 |
| publisher | Alfred A. Knopf |
| record_format | marc |
| series2 | A Borzoi book |
| spelling | Carreyrou, John Verfasser (DE-588)1164175270 aut Bad blood secrets and lies in a Silicon Valley startup John Carreyrou First edition New York Alfred A. Knopf 2019 x, 339 Seiten 25 cm txt rdacontent n rdamedia nc rdacarrier A Borzoi book A purposeful life -- The gluebot -- Apple envy -- Goodbye East Paly -- The childhood neighbor -- Sunny -- Dr. J -- The miniLab -- The wellness play -- "Who is LTC Shoemaker?" -- Lighting a Fuisz -- Ian Gibbons -- Chiat\Day -- Going live -- Unicorn -- The grandson -- Fame -- The Hippocratic Oath -- The tip -- The ambush -- Trade secrets -- La mattanza -- Damage control -- The empress has no clothes -- Epilogue In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When John Carreyrou, working at The Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. The biggest corporate fraud since Enron is a cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley Holmes, Elizabeth Anne 1984- Theranos (Firm) History Theranos Inc. (DE-588)1162212322 gnd rswk-swf Europäische Kommission Startup Project (DE-588)1086334183 gnd rswk-swf Geschichte gnd rswk-swf Hematologic equipment industry United States New business enterprises / Corrupt practices / United States / Case studies Corrupt practices United States Case studies Securities fraud United States Case studies Fraud United States Betrug (DE-588)4006249-1 gnd rswk-swf Theranos Inc. (DE-588)1162212322 b Europäische Kommission Startup Project (DE-588)1086334183 b Betrug (DE-588)4006249-1 s 1\p DE-604 Geschichte z 2\p DE-604 Erscheint auch als Online-Ausgabe 978-1-5247-3165-6 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Carreyrou, John Bad blood secrets and lies in a Silicon Valley startup A purposeful life -- The gluebot -- Apple envy -- Goodbye East Paly -- The childhood neighbor -- Sunny -- Dr. J -- The miniLab -- The wellness play -- "Who is LTC Shoemaker?" -- Lighting a Fuisz -- Ian Gibbons -- Chiat\Day -- Going live -- Unicorn -- The grandson -- Fame -- The Hippocratic Oath -- The tip -- The ambush -- Trade secrets -- La mattanza -- Damage control -- The empress has no clothes -- Epilogue Holmes, Elizabeth Anne 1984- Theranos (Firm) History Theranos Inc. (DE-588)1162212322 gnd Europäische Kommission Startup Project (DE-588)1086334183 gnd Hematologic equipment industry United States New business enterprises / Corrupt practices / United States / Case studies Corrupt practices United States Case studies Securities fraud United States Case studies Fraud United States Betrug (DE-588)4006249-1 gnd |
| subject_GND | (DE-588)1162212322 (DE-588)1086334183 (DE-588)4006249-1 |
| title | Bad blood secrets and lies in a Silicon Valley startup |
| title_auth | Bad blood secrets and lies in a Silicon Valley startup |
| title_exact_search | Bad blood secrets and lies in a Silicon Valley startup |
| title_full | Bad blood secrets and lies in a Silicon Valley startup John Carreyrou |
| title_fullStr | Bad blood secrets and lies in a Silicon Valley startup John Carreyrou |
| title_full_unstemmed | Bad blood secrets and lies in a Silicon Valley startup John Carreyrou |
| title_short | Bad blood |
| title_sort | bad blood secrets and lies in a silicon valley startup |
| title_sub | secrets and lies in a Silicon Valley startup |
| topic | Holmes, Elizabeth Anne 1984- Theranos (Firm) History Theranos Inc. (DE-588)1162212322 gnd Europäische Kommission Startup Project (DE-588)1086334183 gnd Hematologic equipment industry United States New business enterprises / Corrupt practices / United States / Case studies Corrupt practices United States Case studies Securities fraud United States Case studies Fraud United States Betrug (DE-588)4006249-1 gnd |
| topic_facet | Holmes, Elizabeth Anne 1984- Theranos (Firm) History Theranos Inc. Europäische Kommission Startup Project Hematologic equipment industry United States New business enterprises / Corrupt practices / United States / Case studies Corrupt practices United States Case studies Securities fraud United States Case studies Fraud United States Betrug |
| work_keys_str_mv | AT carreyroujohn badbloodsecretsandliesinasiliconvalleystartup |